Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Alloway

Showing results (31-40 of 164) with videos related to

Pageof 17
Sort By:
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|January 19, 2006
Can immunonutrients reduce rejection rates in African Americans?J Wesley Alexander, Hope R Goodman, Rita R Alloway, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 25, 2016
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover StudyS Tremblay, V Nigro, J Weinberg, et al.
Current Opinion in Organ Transplantation|August 12, 2009
Proteasome inhibition for antibody-mediated rejectionJason J Everly, R Carlin Walsh, Rita R Alloway, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 5, 2014
Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipientsRita R Alloway, Devin E Eckhoff, W Kenneth Washburn, et al.
Transplantation|May 30, 2013
Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipientsA Osama Gaber, Rita R Alloway, Kenneth Bodziak, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2016
Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path ForwardM D Stegall, R E Morris, R R Alloway, et al.
Pediatric Transplantation|September 3, 2011
Proteasome inhibitor therapy for antibody-mediated rejectionE S Woodle, R C Walsh, R R Alloway, et al.
Current Transplantation Reports|October 10, 2019
High Dimensional Renal Profiling: Towards a Better Understanding or Renal Transplant Immune SuppressionCyd M Castro-Rojas, Rita R Alloway, E Steve Woodle, et al.
Transplantation Proceedings|June 15, 2004
African-American ethnicity is no longer a risk factor for early adverse outcomes in simultaneous kidney-pancreas transplantation with contemporary immunosuppressionJ Rogers, R J Stratta, R R Alloway, et al.
Journal of Transplant Coordination : Official Publication of the North American Transplant Coordinators Organization (NATCO)|September 1, 1996
Use of FK506 immunosuppressive therapy in pancreas transplantationD S Elmer, T Nyman, D K Hathaway, et al.
Pageof 17

Showing results (31-40 of 164) with videos related to

Sort By:
Pageof 17
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|January 19, 2006
Can immunonutrients reduce rejection rates in African Americans?J Wesley Alexander, Hope R Goodman, Rita R Alloway, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 25, 2016
A Steady-State Head-to-Head Pharmacokinetic Comparison of All FK-506 (Tacrolimus) Formulations (ASTCOFF): An Open-Label, Prospective, Randomized, Two-Arm, Three-Period Crossover StudyS Tremblay, V Nigro, J Weinberg, et al.
Current Opinion in Organ Transplantation|August 12, 2009
Proteasome inhibition for antibody-mediated rejectionJason J Everly, R Carlin Walsh, Rita R Alloway, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 5, 2014
Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipientsRita R Alloway, Devin E Eckhoff, W Kenneth Washburn, et al.
Transplantation|May 30, 2013
Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipientsA Osama Gaber, Rita R Alloway, Kenneth Bodziak, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2016
Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path ForwardM D Stegall, R E Morris, R R Alloway, et al.
Pediatric Transplantation|September 3, 2011
Proteasome inhibitor therapy for antibody-mediated rejectionE S Woodle, R C Walsh, R R Alloway, et al.
Current Transplantation Reports|October 10, 2019
High Dimensional Renal Profiling: Towards a Better Understanding or Renal Transplant Immune SuppressionCyd M Castro-Rojas, Rita R Alloway, E Steve Woodle, et al.
Transplantation Proceedings|June 15, 2004
African-American ethnicity is no longer a risk factor for early adverse outcomes in simultaneous kidney-pancreas transplantation with contemporary immunosuppressionJ Rogers, R J Stratta, R R Alloway, et al.
Journal of Transplant Coordination : Official Publication of the North American Transplant Coordinators Organization (NATCO)|September 1, 1996
Use of FK506 immunosuppressive therapy in pancreas transplantationD S Elmer, T Nyman, D K Hathaway, et al.
Pageof 17